nVerses Capital LLC Acquires New Shares in Core Laboratories Inc. (NYSE:CLB)

nVerses Capital LLC bought a new position in shares of Core Laboratories Inc. (NYSE:CLB) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2,600 shares of the oil and gas company’s stock, valued at approximately $48,000.

Several other large investors also recently bought and sold shares of CLB. CWM LLC boosted its position in shares of Core Laboratories by 1,178.6% in the 1st quarter. CWM LLC now owns 3,580 shares of the oil and gas company’s stock worth $61,000 after buying an additional 3,300 shares in the last quarter. Congress Wealth Management LLC DE lifted its holdings in shares of Core Laboratories by 40.8% in the first quarter. Congress Wealth Management LLC DE now owns 183,282 shares of the oil and gas company’s stock valued at $3,130,000 after purchasing an additional 53,090 shares in the last quarter. Norden Group LLC acquired a new stake in shares of Core Laboratories in the first quarter valued at approximately $394,000. Van ECK Associates Corp increased its stake in shares of Core Laboratories by 9.0% during the 1st quarter. Van ECK Associates Corp now owns 639,071 shares of the oil and gas company’s stock worth $10,915,000 after purchasing an additional 52,639 shares in the last quarter. Finally, GSA Capital Partners LLP raised its position in shares of Core Laboratories by 177.0% during the 1st quarter. GSA Capital Partners LLP now owns 38,827 shares of the oil and gas company’s stock worth $663,000 after purchasing an additional 24,812 shares during the last quarter. Institutional investors and hedge funds own 97.81% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on CLB. Bank of America decreased their price target on shares of Core Laboratories from $16.00 to $15.00 and set an “underperform” rating on the stock in a research note on Monday, July 15th. StockNews.com downgraded Core Laboratories from a “hold” rating to a “sell” rating in a research report on Tuesday, September 17th. Stifel Nicolaus lifted their price target on Core Laboratories from $18.00 to $22.00 and gave the company a “hold” rating in a report on Friday, July 26th. Finally, Piper Sandler cut their price objective on shares of Core Laboratories from $18.00 to $17.00 and set a “neutral” rating on the stock in a report on Monday, July 15th. Two investment analysts have rated the stock with a sell rating and two have assigned a hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $18.00.

Core Laboratories Trading Down 7.4 %

Shares of CLB opened at $17.25 on Wednesday. The stock’s fifty day simple moving average is $18.63 and its 200 day simple moving average is $18.97. Core Laboratories Inc. has a twelve month low of $13.82 and a twelve month high of $25.13. The company has a current ratio of 2.39, a quick ratio of 1.68 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $809.03 million, a P/E ratio of 19.60, a price-to-earnings-growth ratio of 1.08 and a beta of 2.36.

Core Laboratories (NYSE:CLB) last released its quarterly earnings data on Wednesday, July 24th. The oil and gas company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.01. The business had revenue of $130.58 million for the quarter, compared to analyst estimates of $132.85 million. Core Laboratories had a return on equity of 15.20% and a net margin of 5.44%. The company’s revenue was up 2.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.23 EPS. On average, equities research analysts forecast that Core Laboratories Inc. will post 0.8 earnings per share for the current year.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.